Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maanasa Gowda"'
Autor:
Maanasa Gowda, Franco Locatelli, Tommaso Stefanelli, Norbert Hollaender, Shahrukh K. Hashmi, Robert Zeiser, Mary E.D. Flowers, Fitzroy Dawkins, Ronjon Chakraverty, Stephanie J. Lee, Nicola Polverelli, Takanori Teshima, Ron Ram
Publikováno v:
Blood. 136:22-24
BACKGROUND Standard first-line treatment of cGVHD includes systemic corticosteroids; however, about 50% of patients (pts) are steroid refractory or dependent (SR/D) and require additional treatment. The best second-line therapy option has not yet bee
Autor:
Franco Locatelli, Tommaso Stefanelli, Valkal Bhatt, Shashikant Apte, Nada Hamad, Stephanie J. Lee, Francesca Bonifazi, Takanori Teshima, Jackie Han, Kentaro Fukushima, Maanasa Gowda, Ivan S. Moiseev, Juan Carlos Vallejo Llamas, Joseph Pidala, Francis Ayuk, Robert Zeiser, Tsila Zuckerman, Mike Zuurman
Publikováno v:
Blood. 138:3909-3909
BACKGROUND Approximately 50% of patients (pts) who receive initial cGVHD therapy are steroid refractory or dependent (SR/D); standard second-line therapy has yet to be established. Quality of life (QOL) in these pts is poor and worsens with disease s
Autor:
Norbert Hollaender, Ronjon Chakraverty, Maanasa Gowda, Franco Locatelli, Stephanie J. Lee, Ron Ram, Tommaso Stefanelli, Shahrukh K. Hashmi, Takanori Teshima, Peter Langmuir, Nicola Polverelli, Robert Zeiser
Publikováno v:
Web of Science
Autor:
Ittershagen, Stacie, Ericson, Solveig, Eldjerou, Lamis, Shojaee, Ali, Bleickardt, Eric, Patel, Manisha, Taran, Tetiana, Anak, Oezlem, Hall, Charlene, Leung, Mimi, Roccoberton, Deborah, Salmon, Florence, Fuchs, Miriam, Romanov, Vadim, Lebwohl, David
Publikováno v:
Current Hematologic Malignancy Reports; Feb2019, Vol. 14 Issue 1, p47-55, 9p
Publikováno v:
Drug Week; 12/22/2023, p781-781, 1p
Publikováno v:
Pharmacoepidemiology & Drug Safety; Aug2011 Supplement, Vol. 20 Issue S1, pS1-S364, 364p